H Bröll

1.2k total citations
48 papers, 750 citations indexed

About

H Bröll is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, H Bröll has authored 48 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 11 papers in Orthopedics and Sports Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in H Bröll's work include Rheumatoid Arthritis Research and Therapies (16 papers), Bone health and osteoporosis research (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). H Bröll is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Bone health and osteoporosis research (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). H Bröll collaborates with scholars based in Austria, Germany and Switzerland. H Bröll's co-authors include G Partsch, G Steiner, J S Smolen, Attila Dunky, B.F. Leeb, P. Peichl, W Kumpan, Burkhard F. Leeb, Ernst Wagner and Josef S Smolen and has published in prestigious journals such as Annals of the Rheumatic Diseases, Bone and Toxicology and Applied Pharmacology.

In The Last Decade

H Bröll

44 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Bröll Austria 15 352 219 175 147 126 48 750
Yasunori Kageyama Japan 19 407 1.2× 381 1.7× 167 1.0× 110 0.7× 156 1.2× 50 965
O Huber-Bruning Netherlands 18 690 2.0× 132 0.6× 87 0.5× 93 0.6× 109 0.9× 29 1.0k
İsmail Şimşek Türkiye 16 340 1.0× 132 0.6× 81 0.5× 39 0.3× 195 1.5× 54 697
Elena Ossipova Sweden 13 643 1.8× 250 1.1× 76 0.4× 59 0.4× 331 2.6× 30 1.1k
Akihide Nampei Japan 16 409 1.2× 122 0.6× 118 0.7× 350 2.4× 357 2.8× 38 1.2k
Hideki Tsuboi Japan 19 414 1.2× 111 0.5× 125 0.7× 374 2.5× 362 2.9× 74 1.2k
Christina Böhm Germany 15 216 0.6× 230 1.1× 56 0.3× 123 0.8× 514 4.1× 20 871
N. T. CHEUNG United Kingdom 7 299 0.8× 190 0.9× 147 0.8× 15 0.1× 105 0.8× 10 597
Nobunori Takahashi Japan 18 492 1.4× 206 0.9× 116 0.7× 30 0.2× 266 2.1× 108 996
Peter van Lent Netherlands 15 312 0.9× 284 1.3× 42 0.2× 42 0.3× 358 2.8× 21 908

Countries citing papers authored by H Bröll

Since Specialization
Citations

This map shows the geographic impact of H Bröll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Bröll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Bröll more than expected).

Fields of papers citing papers by H Bröll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Bröll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Bröll. The network helps show where H Bröll may publish in the future.

Co-authorship network of co-authors of H Bröll

This figure shows the co-authorship network connecting the top 25 collaborators of H Bröll. A scholar is included among the top collaborators of H Bröll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Bröll. H Bröll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kullich, Werner, Ernst Wagner, U Stuby, et al.. (2014). Reduced ubiquinone plasma levels and oxidative stress in ankylosing spondylitis and rheumatoid arthritis. 2(2). 44. 1 indexed citations
2.
Sieghart, Daniela, et al.. (2014). Hydrogen sulphide decreases IL ‐1β‐induced activation of fibroblast‐like synoviocytes from patients with osteoarthritis. Journal of Cellular and Molecular Medicine. 19(1). 187–197. 45 indexed citations
3.
Hobl, Eva‐Luise, Robert M. Mader, Bernd Jilma, et al.. (2012). A Randomized, Double-Blind, Parallel, Single-Site Pilot Trial to Compare Two Different Starting Doses of Methotrexate in Methotrexate-Naïve Adult Patients with Rheumatoid Arthritis. Clinical Therapeutics. 34(5). 1195–1203. 16 indexed citations
4.
Leeb, Burkhard F., Hans‐Peter Brezinschek, Manfred Herold, et al.. (2009). The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project. Clinical Rheumatology. 29(2). 167–174. 5 indexed citations
5.
Dorner, Thomas E., et al.. (2009). Health-related quality of life in patients with osteopenia or osteoporosis with and without fractures in a geriatric rehabilitation department. Wiener Medizinische Wochenschrift. 159(9-10). 235–240. 22 indexed citations
6.
Gundert‐Remy, Ursula, Sandra Noack, Ulrike Bernauer, H Bröll, & Barbara Heinrich-Hirsch. (2004). Establishment of a rapid TaqMan((R))-assay for genotyping polymorphic alleles of cytochrome P450 enzymes in human tissue. Toxicology and Applied Pharmacology. 197(3). 255–255. 2 indexed citations
7.
Peichl, P., et al.. (2001). Serum crosslaps in comparison to serum osteocalcin and urinary bone resorption markers. Clinical Biochemistry. 34(2). 131–139. 32 indexed citations
8.
Peichl, P., et al.. (2000). Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy. Gynecological Endocrinology. 14(5). 374–381. 10 indexed citations
9.
Peichl, P., et al.. (1999). Anti-IL-8 autoantibodies and complexes in rheumatoid arthritis: polyclonal activation in chronic synovial tissue inflammation. Rheumatology International. 18(4). 141–145. 33 indexed citations
10.
Peichl, P., B. Rintelen, W Kumpan, & H Bröll. (1999). Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy. Gynecological Endocrinology. 13(1). 7–14. 25 indexed citations
11.
Peichl, P., et al.. (1998). Association Between Female Sex Hormones and Biochemical Markers of Bone Turnover in Peri- and Postmenopausal Women. Calcified Tissue International. 62(5). 388–394. 19 indexed citations
12.
13.
Partsch, G, G Steiner, B.F. Leeb, et al.. (1997). Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.. PubMed. 24(3). 518–23. 233 indexed citations
14.
Partsch, G, P Petera, B.F. Leeb, et al.. (1994). HIGH FREE AND LATENT COLLAGENASE ACTIVITY IN PSORIATIC ARTHRITIS SYNOVIAL FLUIDS. Lara D. Veeken. 33(8). 702–706. 4 indexed citations
15.
Partsch, G, et al.. (1991). Complement C3 cleavage product in synovial fluids detected by immunofixation.. PubMed. 50(2). 82–5. 12 indexed citations
16.
Dunky, Attila, R Eberl, N Thumb, et al.. (1990). Tenoxicam Versus Diclofenac Retard in Osteoarthritis of the Knee. Clinical Drug Investigation. 2(S3). 47–48. 1 indexed citations
17.
Haberhauer, G & H Bröll. (1989). Drug-induced anticentromere antibody?. PubMed. 48(2). 99–100. 1 indexed citations
18.
Partsch, G, et al.. (1988). The influence of synovial fluids from patients with rheumatic diseases on chick embryo fibroblasts.. PubMed. 10(2). 67–77. 2 indexed citations
19.
Bröll, H, et al.. (1976). Comparative Clinical Trial with a New Substance, Diftalone, Versus Indomethacin in 30 Patients Affected with Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 5(3). 145–150. 1 indexed citations
20.
Bröll, H, et al.. (1973). [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].. PubMed. 85(4). 59–63. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasunori Kageyama Breakdown of academic impact, for papers by O Huber-Bruning Breakdown of academic impact, for papers by İsmail Şimşek Breakdown of academic impact, for papers by Elena Ossipova Breakdown of academic impact, for papers by Akihide Nampei Breakdown of academic impact, for papers by Hideki Tsuboi Breakdown of academic impact, for papers by Christina Böhm Breakdown of academic impact, for papers by N. T. CHEUNG Breakdown of academic impact, for papers by Nobunori Takahashi Breakdown of academic impact, for papers by Peter van Lent
Rankless by CCL
2026